TherapeuticsMD (TXMD) Amortizatization of Intangibles (2011 - 2026)
TherapeuticsMD's (TXMD) quarterly Amortizatization of Intangibles came in at $234000.0 in Q2 2026, up 8.33% on a YoY basis from $216000.0 in Q2 2025, and up 1.3% quarter-over-quarter from $231000.0 in Q1 2026.
Powered by 
Analysis
TherapeuticsMD (TXMD) Amortizatization of Intangibles (2011 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has reported Amortizatization of Intangibles for 5 consecutive years, with $234000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Amortizatization of Intangibles rose 8.33% year-over-year to $234000.0; the trailing twelve-month figure through Jun 2026 stood at $835000.0 (up 125.68% YoY), and the FY2025 full-year result was $809000.0, up 4.93% from the prior year.
- Amortizatization of Intangibles rose to $234000.0 in Q2 2026 per TXMD's latest filing, from $231000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $234000.0 in Q2 2026 and bottomed at $154000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | - |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 984.00 Mn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 4.33 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | 234,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 234,000.00 |
| Mar 31, 2026 | 231,000.00 |
| Jun 30, 2025 | 216,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Mar 31, 2013 | 1.10 Mn |
| Dec 31, 2012 | 444,865.00 |
| Sep 30, 2012 | 50,099.00 |
| Jun 30, 2012 | 1.06 Mn |
| Mar 31, 2012 | 53,292.00 |
| Dec 31, 2011 | 10,769.00 |
| Sep 30, 2011 | 14,360.00 |
| Jun 30, 2011 | 3,590.00 |